TAIPEI, SHANGHAI, and SAN FRANCISCO, Nov. 5, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and ...

The world's largest collection of curated eye imaging and linked clinical data is expanding across the country, in an ...

Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.

By analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce ...

Cornell researchers received a $5.1 million NIH grant to establish the Autism Replication, Validation, and Reproducibility ...

Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...

Resurgence Behavioral Health has published a new educational resource titled “Attending Inpatient Rehab for Couples with ...

Nearly half of all women aged younger than 40 who live with advanced breast cancer have children under the age of 18, ...

An estimated 50% of patients with SLE will develop lupus nephritis in their lifetime, with people of African descent more ...

Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court's decision denying Pfizer's request for a temporary restraining order to prevent Metsera, Inc.

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Third Quarter 2025 Financial Results: Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational ...